Nivagen Pharmaceuticals' Unattributed Round

Nivagen Pharmaceuticals raised a round of funding on September 14, 2017.

Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. The company's vision is to deliver high quality …

Articles about Nivagen Pharmaceuticals' Unattributed Round: